Novartis to Acquire Tourmaline Bio, Boosting Cardiovascular Pipeline with Pacibekitug for ASCVD Treatment Read more
Gilead Partners with PEPFAR to Provide Twice-Yearly HIV Prevention to 2 Million People in Low-Income Countries Read more
Amgen to Invest Over $600 Million in New Science and Innovation Center at U.S. Headquarters Read more
Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced NSCLC Read more